| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | CA2643267A1 N-formyl hydroxylamine compounds |
| 09/20/2007 | CA2643222A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs |
| 09/20/2007 | CA2643066A1 Pyrazole compounds |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | CA2632807A1 Inhibitors of iap |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1833823A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
| 09/19/2007 | EP1833821A2 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
| 09/19/2007 | EP1833820A1 Selective inhibitors of erk protein kinase and uses therof |
| 09/19/2007 | EP1833819A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 09/19/2007 | EP1833818A1 6-(1h-pyrazol-5-yl)-1,3,5-triazine derivatives and their use as protective agents against uv radiation |
| 09/19/2007 | EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 09/19/2007 | EP1833482A2 Compounds and therapeutical use thereof |
| 09/19/2007 | EP1833480A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 09/19/2007 | EP1585734A4 Anti-inflammatory medicaments |
| 09/19/2007 | CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors |
| 09/19/2007 | CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 09/19/2007 | CN101039929A Novel anthranilamides useful for controlling invertebrate pests |
| 09/19/2007 | CN101039920A 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 09/19/2007 | CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 09/19/2007 | CN101039918A Small molecule modulators of cytokine activity |
| 09/19/2007 | CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers |
| 09/19/2007 | CN101039915A Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity |
| 09/19/2007 | CN101039907A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 09/19/2007 | CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338058C 新的吲哚衍生物 The new indole derivatives |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271269 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods |
| 09/18/2007 | US7271265 Cyanine compounds and their application as quenching compounds |
| 09/18/2007 | US7271263 Process for production of substituted aniline compound |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271167 Compounds, compositions, and methods |
| 09/18/2007 | US7271160 Firt and second hsp(heat shock protein)-binding moieties joined by a linker, which bind to the pocket of hsp90 with which ansamycin antibiotics bind; linked geldanamycin, for example; treating cancer |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007103584A2 Polyamides for treating human papilloma virus |
| 09/13/2007 | WO2007103233A2 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007102059A1 Sulfonyl benzimidazole derivatives |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007079199A3 Substituted bis-amide metalloprotease inhibitors |
| 09/13/2007 | US20070213561 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide |
| 09/13/2007 | US20070213539 Novel synthesis of irbesartan |
| 09/13/2007 | US20070213535 Process for the manufacture of aripiprazole by using purified carbostyril compounds such as 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones |
| 09/13/2007 | US20070213533 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines |
| 09/13/2007 | US20070213532 1-(4,6-dimethoxypyrimidine-2-yl)-2-propanone; intermediate for preparing herbicidyl 2-(alpha-hydroxy-o-aminobenzyl)-4,6-dimethoxypyrimidines |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213375 Triazole derivatives useful as Axl inhibitors |
| 09/13/2007 | US20070213371 Dibenzyl Amine Compounds and Derivatives |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213359 Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereof |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213345 Immuno Inhibitory Pyrazolone Compounds |
| 09/13/2007 | US20070213340 Farnesyl protein transferase inhibitors |
| 09/13/2007 | US20070213339 Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213325 Multi-cyclic compound and method of use |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213319 Inflammatory diseases and dysproliferative diseases such as rheumatoid arthritis, cancer; N2-(2-(phenylthiobenzyl)-2,4-diamino-quinazolines |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070213315 Modulators of muscarinic receptors |
| 09/13/2007 | US20070213314 Dibenzyl Amine Compounds and Derivatives |
| 09/13/2007 | US20070213302 pyrazoles; diabetes, cardiometabolic disorders; side effects reduction |
| 09/13/2007 | US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/12/2007 | EP1832589A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto |
| 09/12/2007 | EP1831208A1 Quaternary ammonium salts as m3 antagonists |
| 09/12/2007 | EP1831202A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 09/12/2007 | EP1831201A1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 09/12/2007 | EP1831197A2 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 09/12/2007 | EP1831183A1 1,6-substituted (3r,6r)-3-(2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1830852A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 09/12/2007 | EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1613304B1 Dpp-iv inhibitors |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1253149B1 Sulfate salt of quinolonecarboxylic acid derivative and use thereof |
| 09/12/2007 | CN101035783A Urea derivatives as calcium channel blockers |
| 09/12/2007 | CN101035780A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 09/12/2007 | CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 09/12/2007 | CN101035769A Pyrimidine urea derivatives as kinase inhibitors |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |